We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYT icon
1501
New York Times
NYT
$12.2B
$35K ﹤0.01%
1,088
PVH icon
1502
PVH
PVH
$4.01B
$35K ﹤0.01%
341
+159
+87% +$15.2K
WIT icon
1503
Wipro
WIT
$19B
$35K ﹤0.01%
19,082
-12,060
-39% -$22.7K
LTRPA
1504
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$35K ﹤0.01%
4,822
WFC.PRQ
1505
DELISTED
Wells Fargo & Co.
WFC.PRQ
$35K ﹤0.01%
1,300
CVIA
1506
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$35K ﹤0.01%
17,296
-45,766
-73% -$73.9K
BBVA icon
1507
Banco Bilbao Vizcaya Argentaria
BBVA
$147B
$34K ﹤0.01%
6,144
+2,170
+55% +$11.6K
BLD
1508
DELISTED
TopBuild
BLD
$34K ﹤0.01%
340
+137
+67% +$14.3K
CTRE icon
1509
CareTrust REIT
CTRE
$10.1B
$34K ﹤0.01%
1,704
-179
-10% -$3.92K
FORM icon
1510
FormFactor
FORM
$6.88B
$34K ﹤0.01%
1,332
+207
+18% +$4.67K
J icon
1511
Jacobs Solutions
J
$16.6B
$34K ﹤0.01%
461
+159
+53% +$12K
LAD icon
1512
Lithia Motors
LAD
$8.17B
$34K ﹤0.01%
232
+79
+52% +$11.9K
PAC icon
1513
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$34K ﹤0.01%
294
PBF icon
1514
PBF Energy
PBF
$7.22B
$34K ﹤0.01%
1,123
SQM icon
1515
Sociedad Química y Minera de Chile
SQM
$19.1B
$34K ﹤0.01%
1,298
LSXMB
1516
DELISTED
Liberty Media Corporation Series B Liberty SiriusXM Common Stock
LSXMB
$34K ﹤0.01%
982
MKTAY
1517
DELISTED
MAKITA CORP SPONS ADR
MKTAY
$34K ﹤0.01%
992
-166
-14% -$5.69K
EON
1518
DELISTED
E.ON AG ADS (REPTG 1/3 ORD SHS)
EON
$34K ﹤0.01%
3,271
-807
-20% -$8.39K
AEG icon
1519
Aegon
AEG
$13.6B
$33K ﹤0.01%
8,061
+106
+1% +$433
CGNX icon
1520
Cognex
CGNX
$10B
$33K ﹤0.01%
600
EQR icon
1521
Equity Residential
EQR
$25.5B
$33K ﹤0.01%
416
-95
-19% -$8.09K
FRT icon
1522
Federal Realty Investment Trust
FRT
$10.9B
$33K ﹤0.01%
259
+215
+489% +$28.6K
NMRK icon
1523
Newmark Group
NMRK
$2.88B
$33K ﹤0.01%
2,505
+418
+20% +$4.88K
PPLT
1524
abrdn Physical Platinum Shares ETF
PPLT
$1.83B
$33K ﹤0.01%
+3,700
New +$31.7K
PCOM
1525
DELISTED
Points.com Inc. Common Shares
PCOM
$33K ﹤0.01%
2,167

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.